Home Cart 0 Sign in  
X

[ CAS No. 394-47-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 394-47-8
Chemical Structure| 394-47-8
Chemical Structure| 394-47-8
Structure of 394-47-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 394-47-8 ]

Related Doc. of [ 394-47-8 ]

Alternatived Products of [ 394-47-8 ]

Product Details of [ 394-47-8 ]

CAS No. :394-47-8 MDL No. :MFCD00001773
Formula : C7H4FN Boiling Point : -
Linear Structure Formula :- InChI Key :GDHXJNRAJRCGMX-UHFFFAOYSA-N
M.W : 121.11 Pubchem ID :67855
Synonyms :

Calculated chemistry of [ 394-47-8 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.12
TPSA : 23.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.6
Log Po/w (XLOGP3) : 1.63
Log Po/w (WLOGP) : 2.12
Log Po/w (MLOGP) : 1.88
Log Po/w (SILICOS-IT) : 2.24
Consensus Log Po/w : 1.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.11
Solubility : 0.938 mg/ml ; 0.00774 mol/l
Class : Soluble
Log S (Ali) : -1.74
Solubility : 2.19 mg/ml ; 0.0181 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.234 mg/ml ; 0.00193 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.3

Safety of [ 394-47-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P210-P261-P305+P351+P338 UN#:N/A
Hazard Statements:H227-H302-H315-H319-H335-H412 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 394-47-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 394-47-8 ]
  • Downstream synthetic route of [ 394-47-8 ]

[ 394-47-8 ] Synthesis Path-Upstream   1~30

  • 1
  • [ 394-47-8 ]
  • [ 874-05-5 ]
YieldReaction ConditionsOperation in experiment
44% With hydrazine In butan-1-ol for 5 h; Heating / reflux Example 21.1: Preparation of 3-Hydroxy-4-oxo-4,6-dihydro-pyrimido[l,2- 6]indazole-2-carboxylic acid methyl ester; <n="129"/>Step 1:2-Fluorobenzonitrile (605 mg, 5 mmol) and 85percent aqueous hydrazine hydrate (352mg, 6mmol) were mixed with 1-butanol (3 mL). The mixture was heated at reflux with stirring for 5 h then cooled to room temperature. The resulting precipitate was collected by filtration and washed with dichloromethane and the filter cake was dried in vacuo to give 3 -amino benzpyrazole (293 mg, 44 percent).1H NMR (300 MHz, D6-DMSO): δ 5.26-5.36 (brs, 2H), 6.84-6.93 (m, IH), 7.18-7.24 (m, 2H), 7.67 (dt, J=8.1, 0.9 Hz, IH), 11.33 (s, IH).
Reference: [1] Chemical Communications, 2014, vol. 50, # 85, p. 12911 - 12914
[2] Advanced Synthesis and Catalysis, 2016, vol. 358, # 13, p. 2126 - 2133
[3] Patent: WO2008/77188, 2008, A1, . Location in patent: Page/Page column 127-128
[4] Organic Process Research and Development, 2011, vol. 15, # 3, p. 565 - 569
[5] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 23, p. 5293 - 5297
[6] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 1, p. 321 - 329
[7] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3088 - 3100
[8] Journal of Medicinal Chemistry, 2013, vol. 56, # 5, p. 1946 - 1960
[9] Patent: CN105523955, 2016, A, . Location in patent: Paragraph 0167; 0168; 0286
[10] Patent: US2008/103182, 2008, A1, . Location in patent: Page/Page column 13
  • 2
  • [ 394-47-8 ]
  • [ 302-01-2 ]
  • [ 874-05-5 ]
YieldReaction ConditionsOperation in experiment
8.2% at 160℃; for 0.333333 h; Irradiation To 2-fluorobenzonitrile (1 mL, 9.08 mmol) in EtOH (10 mL) was added hydrazine (0.855 mL, 27.2 mmol) and the reaction was heated to 1600C in a microwave for 20 min. LCMS m/z 134.1(M + H)+. The solvents were removed in vacuo and the residue was quenched with water (10 mL) and ethyl acetate (20 mL). The organic layer was washed with water (10 mL), brine (10 mL), dried (MgSO4) to afford 140A (O. lg, 8.2percent) as an oil which was used directly in the next step.
Reference: [1] Patent: WO2008/157162, 2008, A1, . Location in patent: Page/Page column 208
  • 3
  • [ 394-47-8 ]
  • [ 36216-80-5 ]
YieldReaction ConditionsOperation in experiment
27% With potassium <i>tert</i>-butylate; acide acetohydroxamique In N,N-dimethyl-formamide at 20℃; for 5.5 h; Example 1; N-1,2-Benzisoxazol-3-yl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide; (1) 1,2-Benzisoxazol-3-amine; To a solution of acetohydroxamic acid (10.0 g, 133 mmol) in N,N-dimethylformamide (150 ml) was added potassium tert-butoxide (14.9 g, 133 mmol), and the mixture was stirred at room temperature for 30 minutes. 2-Fluorobenzonitrile (18.0 g, 133 mmol) was added thereto, followed by stirring at room temperature for 5 hours. The reaction mixture was poured to water and extracted with ethyl acetate. The extract wase washed with water and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was recrystallized from hexane to give 4.80 g (27.0percent) of the desired product as a solid. 1H-NMR (CDCl3) δ; 4.43 (2H, br s), 7.23 - 7.28 (1H, m), 7.43 (1H, d, J = 9.3 Hz), 7.50 - 7.56 (2H, m).
Reference: [1] Patent: EP1813606, 2007, A1, . Location in patent: Page/Page column 24
[2] Journal of Organic Chemistry, 2000, vol. 65, # 10, p. 2924 - 2932
[3] Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 1293 - 1298
[4] Patent: EP2460799, 2012, A1,
[5] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 18, p. 6157 - 6165
[6] Patent: WO2008/77188, 2008, A1,
  • 4
  • [ 546-88-3 ]
  • [ 394-47-8 ]
  • [ 36216-80-5 ]
YieldReaction ConditionsOperation in experiment
53.7% With potassium carbonate In N,N-dimethyl-formamide at 80℃; 2- fluorobenzonitrile (6.1g, 50.0mmol), acetohydroxamic acid (5.6g, 75.0mmol) and potassium carbonate (10.4g, 75mmol) was dissolved in DMF (40mL), the mixture was stirred overnight and heated to 80 .With ethyl acetate (100mL × 2) and extracted.The combined organic phases were washed with water (100 mL × 2), saturated brine (100 mL), dried over anhydrous sodium sulfate.Filtered, and the solvent was evaporated under reduced pressure and the crude product purified by column chromatography (petroleum ether / ethyl acetate (v / v) = 4/1), as a white solid (3.6g, 53.7percent).
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 17, p. 2885 - 2886
[2] Patent: CN104530046, 2016, B, . Location in patent: Paragraph 0202; 0203; 0204; 0205
  • 5
  • [ 107-29-9 ]
  • [ 394-47-8 ]
  • [ 36216-80-5 ]
Reference: [1] Patent: WO2005/89753, 2005, A2, . Location in patent: Page/Page column 28
  • 6
  • [ 394-47-8 ]
  • [ 36216-80-5 ]
Reference: [1] Green Chemistry, 2013, vol. 15, # 3, p. 780 - 785
  • 7
  • [ 394-47-8 ]
  • [ 113-00-8 ]
  • [ 1899-48-5 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 39, p. 31226 - 31230
  • 8
  • [ 593-85-1 ]
  • [ 394-47-8 ]
  • [ 1899-48-5 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 5, p. 502 - 507
  • 9
  • [ 394-47-8 ]
  • [ 124-46-9 ]
  • [ 1899-48-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3135 - 3143
[2] Journal of Heterocyclic Chemistry, 1988, vol. 25, p. 1173 - 1177
  • 10
  • [ 394-47-8 ]
  • [ 89-99-6 ]
YieldReaction ConditionsOperation in experiment
60% With potassium borohydride; copper dichloride In water; isopropyl alcohol at 60℃; for 12 h; General procedure: General procedure for the reduction of nitrile by KBH4and CuCl2:To a 10 mL round-bottomed flask was added 2-(4-chlorophenyl)acetonitrile (0.1 5 g, 1 mmol), KBH4 (0.17 g, 3mmol), CuCl2 (0.03 g, 0.25 mmol) and 80 percent isopropanol (1.6mL isopropanol and 0.4 mL water). The reaction completed in8 h at 60 °C as evidenced by TLC (DCM:MeOH 10:1). Thereaction mixture was cooled to 25 °C and removed the solvent.Ethyl acetate (5 mL) was added to the residue, washed withwater (1 mL) and brine (1 mL). The organic layer were dried withanhydrous Na2SO4, filtered and evaporated in vacuo to affordthe crude product.
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 28, p. 8888 - 8891
[2] Synlett, 2001, # 10, p. 1623 - 1625
[3] Small, 2018, vol. 14, # 37,
[4] ChemCatChem, 2017, vol. 9, # 4, p. 559 - 563
[5] Asian Journal of Chemistry, 2015, vol. 27, # 10, p. 3564 - 3566
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 19, p. 7965 - 7983
  • 11
  • [ 96-35-5 ]
  • [ 394-47-8 ]
  • [ 57805-85-3 ]
YieldReaction ConditionsOperation in experiment
48% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 12 h; Heating / reflux Preparation Example 1: Preparation of 3-amino-benzofuran-2-carboxylic acid methyl ester0.22 g (1.18 mmol) of σ-fluorobenzonitrile was dissolved in 5 ml of N5N- dimethylformamide, 0.16 ml (2.18 mmol) of methyl glyconate and 0.62 g (4.54 mmol) of potassium carbonate were added thereto at room temperature, and the mixture was refluxed with heating for 12 hrs. After the reaction was completed, the reaction mixture was diluted with 10 ml of ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, and concentrated under a reduced pressure. The residue was subjected to silica gel column chromatography <n="19"/>(hexane:ethyl acetate = 4:1) to obtain the title compound (0.10 g, 48percent yield).1H NMR (300MHz, DMSO-d6): δ 3.97(s, 3H), 4.98(s, 2H), 7.23-7.28(m, IH), 7.44-7.47(m, 2H), 7.56(d, IH)Mass(m/e, M+): 192
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 22, p. 6362 - 6365
[2] Patent: WO2009/48274, 2009, A2, . Location in patent: Page/Page column 16-17
  • 12
  • [ 394-47-8 ]
  • [ 623-51-8 ]
  • [ 34761-09-6 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 20 h;
Method 1 : 4-Aminobenzothienof3,2-dlpyrimdineSynthesis 1AEthyl 3-amin -carboxylate2-Fluorobenzonitrile (8.25 mmol), diisopropylethylamine (8.25 mmol) and ethyl2-mercaptoacetate (8.25 mmol) in anhydrous Ν,Ν-dimethylformamide (5 mL) was allowed to stir for 30 min at room temperature. Potassium carbonate (8.25 mmol) was added and the solution was heated to 80°C for 20 h. Ice-water was added and the resulting precipitate was filtered off, washing with water to obtain the carboxylate as a white solid (92percent).LCMS rt 7.43, M+H 222; 1H-NMR (CDCI3) δ 7.43 (1H, d, J 8.1 Hz), 7.65 (1H, d, J 8.1 Hz), 7.49-7.44 (1H, m), 7.39-7.34 (1H, m), 4.36 (2H, q, J 7.1 Hz), 1.40 (3H, t, J 7.1 Hz).
86%
Stage #1: With sodium hydride In dimethyl sulfoxide at 20℃; for 0.25 h;
Ethyl thioglycolate 6 (11 mmol) was added to a suspension of sodium hydride (15 mmol) in dry DMSO (10 ml). The mixture was left under stirring for 15 min at rt followed by fluoro-benzonitrile 5 (10 mmol) addition. After stirring over night, the reaction mixture was quenched with ice, forming a yellow precipitate which was filtered to yield aminobenzo[b]thiophene-2-carboxylate.
Reference: [1] Patent: WO2012/131297, 2012, A1, . Location in patent: Page/Page column 85
[2] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 15, p. 3291 - 3297
[3] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 4, p. 1163 - 1172
  • 13
  • [ 394-47-8 ]
  • [ 15332-09-9 ]
  • [ 95-52-3 ]
Reference: [1] Research on Chemical Intermediates, 2012, vol. 38, # 7, p. 1619 - 1628
[2] Research on Chemical Intermediates, 2012, vol. 38, # 7, p. 1619 - 1628
  • 14
  • [ 394-47-8 ]
  • [ 271-44-3 ]
  • [ 15332-09-9 ]
  • [ 95-52-3 ]
Reference: [1] Research on Chemical Intermediates, 2012, vol. 38, # 7, p. 1619 - 1628
  • 15
  • [ 394-47-8 ]
  • [ 3759-28-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 14, p. 2703 - 2718
  • 16
  • [ 394-47-8 ]
  • [ 17417-09-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 537 - 546
[2] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 4, p. 1163 - 1172
[3] Chemical Biology and Drug Design, 2018, vol. 91, # 1, p. 39 - 49
  • 17
  • [ 394-47-8 ]
  • [ 445-28-3 ]
YieldReaction ConditionsOperation in experiment
83% With Acetaldehyde oxime; [(eta.(5)-pentamethylcyclopentadienyl)Rh(H2O)3](OTf)2 In water at 50℃; for 6 h; Schlenk technique A solution of 2-fluorobenzonitrile (121 mg, 1 mmol), [Cp * Rh (H2O)3] [OTf]2(3.0 mg, 0.005 mmol, 0.5 molpercent), acetaldehyde oxime (65 mg, 1.1 mmol) and water (1 ml) were successively added to a 25 ml Schlenk reaction flask.The reaction mixture was reacted at 50 ° C for 6 hours, then cooled to room temperature, and the water was removed by rotary evaporation to remove the title product. The yield was 83percent
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 12, p. 1589 - 1591
[2] RSC Advances, 2014, vol. 4, # 3, p. 1102 - 1106
[3] Journal of Organic Chemistry, 2015, vol. 80, # 8, p. 4148 - 4151
[4] New Journal of Chemistry, 2018, vol. 42, # 19, p. 15572 - 15577
[5] Catalysis Science and Technology, 2016, vol. 6, # 12, p. 4398 - 4409
[6] ChemSusChem, 2011, vol. 4, # 1, p. 104 - 111
[7] Chemistry - A European Journal, 2017, vol. 23, # 60, p. 15210 - 15221
[8] Chemistry - A European Journal, 2008, vol. 14, # 22, p. 6601 - 6605
[9] Chemistry - A European Journal, 2010, vol. 16, # 32, p. 9808 - 9817
[10] RSC Advances, 2014, vol. 4, # 108, p. 63466 - 63474
[11] Patent: CN104744288, 2017, B, . Location in patent: Paragraph 0040; 0041; 0042; 0043
[12] Organometallics, 2011, vol. 30, # 20, p. 5442 - 5451
[13] ChemCatChem, 2017, vol. 9, # 7, p. 1349 - 1353
[14] Tetrahedron Letters, 2000, vol. 41, # 19, p. 3747 - 3749
[15] Organometallics, 2010, vol. 29, # 17, p. 3955 - 3965
[16] ACS Catalysis, 2014, vol. 4, # 6, p. 1901 - 1910
[17] European Journal of Medicinal Chemistry, 1990, vol. 25, # 8, p. 673 - 680
[18] Journal of Medicinal Chemistry, 2009, vol. 52, # 17, p. 5295 - 5298
[19] Tetrahedron Letters, 2010, vol. 51, # 13, p. 1639 - 1641
[20] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 24, p. 5682 - 5686
  • 18
  • [ 446-52-6 ]
  • [ 394-47-8 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2013, vol. 3, # 17, p. 5889 - 5894
  • 19
  • [ 24652-66-2 ]
  • [ 394-47-8 ]
  • [ 445-28-3 ]
Reference: [1] Synthetic Communications, 2013, vol. 43, # 13, p. 1778 - 1786
  • 20
  • [ 64-17-5 ]
  • [ 394-47-8 ]
  • [ 6609-57-0 ]
Reference: [1] Synthetic Communications, 2010, vol. 40, # 14, p. 2122 - 2129
  • 21
  • [ 394-47-8 ]
  • [ 1479-24-9 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: at 0 - 25℃; for 46 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20 - 25℃; for 1 h;
Under nitrogen atmosphere, 30 ML of THF was added to 6.09 g (10 mmol, 1.0 equivalent) of (BrZnCH2COOEt*THF)2..
Under argon atmosphere, a solution of 1.21 g (10 mmol) of 2-fluorobenzonitrile in 5 ML of THF was added dropwise while stirring at 0.similar.5°C.
The mixture was stirred at 20°C.similar.25°C for 46 hours. 15 ML of 10percent hydrochloric acid added dropwise at 20°C or lower, and the mixture was stirred at 20.similar.25°C for 1 hour, followed by dilution with 50 ML of ethyl acetate..
Then, the layers were separated.
The organic layer was washed successively with 15 ML of 1N hydrochloric acid, 20 ML of an aqueous saturated sodium chloride solution, 20 ML (*2) of an aqueous saturated sodium bicarbonate solution, and 20 ML of an aqueous saturated sodium chloride solution..
After washing, the organic layer was dried with anhydrous magnesium sulfate..
Concentration under reduced pressure afforded 1.94 g of the desired product (yield 92percent).1H NMR (CDCl3), (ppm): δ [1.26 (t, J=7.1 Hz), 1.34 (t,J=7.1 Hz)] (3H), [3. 98 (s), 5.84 (s), 12.6 (s)] (2H), 4.17-4.28 (2H, m), 7.08-7.97 (4H, m).
Reference: [1] Patent: EP1471056, 2004, A1, . Location in patent: Page 45-46
  • 22
  • [ 394-47-8 ]
  • [ 57075-81-7 ]
Reference: [1] European Journal of Organic Chemistry, 2006, # 12, p. 2753 - 2765
[2] Patent: WO2006/97220, 2006, A1, . Location in patent: Page/Page column 34
[3] Journal of Medicinal Chemistry, 1990, vol. 33, # 4, p. 1230 - 1241
  • 23
  • [ 394-47-8 ]
  • [ 4039-32-1 ]
  • [ 57075-81-7 ]
Reference: [1] Patent: US6265426, 2001, B1,
  • 24
  • [ 394-47-8 ]
  • [ 79544-27-7 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 64, p. 8974 - 8977
  • 25
  • [ 394-47-8 ]
  • [ 447464-03-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 21, p. 6253 - 6257
  • 26
  • [ 394-47-8 ]
  • [ 159589-71-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2005, vol. 53, # 7, p. 764 - 769
  • 27
  • [ 394-47-8 ]
  • [ 775304-60-4 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 10, p. 1708 - 1716
  • 28
  • [ 394-47-8 ]
  • [ 33240-34-5 ]
  • [ 111982-45-7 ]
YieldReaction ConditionsOperation in experiment
40%
Stage #1: With copper(I) bromide In tetrahydrofuran at 60℃; for 15 h;
Stage #2: With sulfuric acid; water In tetrahydrofuran at 0℃; for 15 h;
Preparation 100; Cvclopentvl- (2-fluoro-phenyl)-methanone Stir 2-Fluorobenzonitrile (5. 0g, 41.01 mmole) in 80 ml of THF with a 2 molar cylcopentyl magnesium bromide THF solution (20.51 ml, 41.01 mmole) and CuBr (0. 100g, 0.697 mmole) for 15 hrs at 60 °C under argon gas. Add al5percent solution of sulfuric acid to the reaction at 0 °C and stir for 15 hrs. Extract the reaction mixture three times with diethyl ether. Combine organic layers and dry over MgS04 and concentrate Purify residue via column chromatography using mixture of Ethyl Acetate and hexanes ; to give 3.085 grams. Yield 40percent MS (ES) = 192.15 (M+1) +.
Reference: [1] Patent: WO2005/66126, 2005, A1, . Location in patent: Page/Page column 83
  • 29
  • [ 137-43-9 ]
  • [ 394-47-8 ]
  • [ 111982-45-7 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 14, p. 2021 - 2028
  • 30
  • [ 57381-51-8 ]
  • [ 25015-63-8 ]
  • [ 870238-67-8 ]
  • [ 394-47-8 ]
Reference: [1] Heterocycles, 2010, vol. 80, # 1, p. 213 - 218
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 394-47-8 ]

Fluorinated Building Blocks

Chemical Structure| 1897-53-6

[ 1897-53-6 ]

2-Fluoroterephthalonitrile

Similarity: 0.97

Chemical Structure| 1003712-20-6

[ 1003712-20-6 ]

2,5-Difluoro-3-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 867367-02-0

[ 867367-02-0 ]

4-Fluoro-3,5-dimethylbenzonitrile

Similarity: 0.95

Chemical Structure| 170572-49-3

[ 170572-49-3 ]

3-Fluoro-4-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 1897-52-5

[ 1897-52-5 ]

2,6-Difluorobenzonitrile

Similarity: 0.92

Aryls

Chemical Structure| 1897-53-6

[ 1897-53-6 ]

2-Fluoroterephthalonitrile

Similarity: 0.97

Chemical Structure| 1003712-20-6

[ 1003712-20-6 ]

2,5-Difluoro-3-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 867367-02-0

[ 867367-02-0 ]

4-Fluoro-3,5-dimethylbenzonitrile

Similarity: 0.95

Chemical Structure| 170572-49-3

[ 170572-49-3 ]

3-Fluoro-4-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 1897-52-5

[ 1897-52-5 ]

2,6-Difluorobenzonitrile

Similarity: 0.92

Nitriles

Chemical Structure| 1897-53-6

[ 1897-53-6 ]

2-Fluoroterephthalonitrile

Similarity: 0.97

Chemical Structure| 1003712-20-6

[ 1003712-20-6 ]

2,5-Difluoro-3-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 867367-02-0

[ 867367-02-0 ]

4-Fluoro-3,5-dimethylbenzonitrile

Similarity: 0.95

Chemical Structure| 170572-49-3

[ 170572-49-3 ]

3-Fluoro-4-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 1897-52-5

[ 1897-52-5 ]

2,6-Difluorobenzonitrile

Similarity: 0.92